In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics

Gian Matteo Rigolin, Elena Saccenti, Emanuele Guardalben, Maurizio Cavallari, Luca Formigaro, Barbara Zagatti, Andrea Visentin, Francesca R. Mauro, Enrico Lista, Cristian Bassi, Laura Lupini, Francesca Maria Quaglia, Antonio Urso, Maria Antonella Bardi, Laura Bonaldi, Eleonora Volta, Elisa Tammiso, Caterina Ilari, Luciana Cafforio, Aurora Melandri & 6 others Francesco Cavazzini, Massimo Negrini, Gianpietro Semenzato, Livio Trentin, Robin Foà, Antonio Cuneo

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Complex karyotype (CK) is a negative prognostic factor in chronic lymphocytic leukaemia (CLL). However, CK is a heterogeneous cytogenetic category. Unbalanced rearrangements were present in 73·3% of 90 CLL patients with CK (i.e. ≥3 chromosome aberrations in the same clone), and were associated with a shorter overall survival (P = 0·025) and a shorter time to first treatment (P = 0·043) by multivariate analysis. Patients with unbalanced rearrangements presented a distinct mRNA expression profile. In conclusion, CLL patients with unbalanced rearrangements might represent a subset of very high-risk CLL patients with distinct clinical and biological characteristics.

Original languageEnglish
Pages (from-to)229-233
Number of pages5
JournalBritish Journal of Haematology
Volume181
Issue number2
DOIs
Publication statusPublished - Apr 1 2018

Fingerprint

B-Cell Chronic Lymphocytic Leukemia
Karyotype
Cytogenetics
Chromosome Aberrations
Multivariate Analysis
Clone Cells
Messenger RNA
Survival
Therapeutics

Keywords

  • chronic lymphocytic leukaemia
  • complex karyotype
  • gene expression profile
  • overall survival
  • time to first treatment

ASJC Scopus subject areas

  • Hematology

Cite this

In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics. / Rigolin, Gian Matteo; Saccenti, Elena; Guardalben, Emanuele; Cavallari, Maurizio; Formigaro, Luca; Zagatti, Barbara; Visentin, Andrea; Mauro, Francesca R.; Lista, Enrico; Bassi, Cristian; Lupini, Laura; Quaglia, Francesca Maria; Urso, Antonio; Bardi, Maria Antonella; Bonaldi, Laura; Volta, Eleonora; Tammiso, Elisa; Ilari, Caterina; Cafforio, Luciana; Melandri, Aurora; Cavazzini, Francesco; Negrini, Massimo; Semenzato, Gianpietro; Trentin, Livio; Foà, Robin; Cuneo, Antonio.

In: British Journal of Haematology, Vol. 181, No. 2, 01.04.2018, p. 229-233.

Research output: Contribution to journalArticle

Rigolin, GM, Saccenti, E, Guardalben, E, Cavallari, M, Formigaro, L, Zagatti, B, Visentin, A, Mauro, FR, Lista, E, Bassi, C, Lupini, L, Quaglia, FM, Urso, A, Bardi, MA, Bonaldi, L, Volta, E, Tammiso, E, Ilari, C, Cafforio, L, Melandri, A, Cavazzini, F, Negrini, M, Semenzato, G, Trentin, L, Foà, R & Cuneo, A 2018, 'In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics', British Journal of Haematology, vol. 181, no. 2, pp. 229-233. https://doi.org/10.1111/bjh.15174
Rigolin, Gian Matteo ; Saccenti, Elena ; Guardalben, Emanuele ; Cavallari, Maurizio ; Formigaro, Luca ; Zagatti, Barbara ; Visentin, Andrea ; Mauro, Francesca R. ; Lista, Enrico ; Bassi, Cristian ; Lupini, Laura ; Quaglia, Francesca Maria ; Urso, Antonio ; Bardi, Maria Antonella ; Bonaldi, Laura ; Volta, Eleonora ; Tammiso, Elisa ; Ilari, Caterina ; Cafforio, Luciana ; Melandri, Aurora ; Cavazzini, Francesco ; Negrini, Massimo ; Semenzato, Gianpietro ; Trentin, Livio ; Foà, Robin ; Cuneo, Antonio. / In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics. In: British Journal of Haematology. 2018 ; Vol. 181, No. 2. pp. 229-233.
@article{137d30219bf44288a06cb8acc6af7283,
title = "In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics",
abstract = "Complex karyotype (CK) is a negative prognostic factor in chronic lymphocytic leukaemia (CLL). However, CK is a heterogeneous cytogenetic category. Unbalanced rearrangements were present in 73·3{\%} of 90 CLL patients with CK (i.e. ≥3 chromosome aberrations in the same clone), and were associated with a shorter overall survival (P = 0·025) and a shorter time to first treatment (P = 0·043) by multivariate analysis. Patients with unbalanced rearrangements presented a distinct mRNA expression profile. In conclusion, CLL patients with unbalanced rearrangements might represent a subset of very high-risk CLL patients with distinct clinical and biological characteristics.",
keywords = "chronic lymphocytic leukaemia, complex karyotype, gene expression profile, overall survival, time to first treatment",
author = "Rigolin, {Gian Matteo} and Elena Saccenti and Emanuele Guardalben and Maurizio Cavallari and Luca Formigaro and Barbara Zagatti and Andrea Visentin and Mauro, {Francesca R.} and Enrico Lista and Cristian Bassi and Laura Lupini and Quaglia, {Francesca Maria} and Antonio Urso and Bardi, {Maria Antonella} and Laura Bonaldi and Eleonora Volta and Elisa Tammiso and Caterina Ilari and Luciana Cafforio and Aurora Melandri and Francesco Cavazzini and Massimo Negrini and Gianpietro Semenzato and Livio Trentin and Robin Fo{\`a} and Antonio Cuneo",
year = "2018",
month = "4",
day = "1",
doi = "10.1111/bjh.15174",
language = "English",
volume = "181",
pages = "229--233",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "2",

}

TY - JOUR

T1 - In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics

AU - Rigolin, Gian Matteo

AU - Saccenti, Elena

AU - Guardalben, Emanuele

AU - Cavallari, Maurizio

AU - Formigaro, Luca

AU - Zagatti, Barbara

AU - Visentin, Andrea

AU - Mauro, Francesca R.

AU - Lista, Enrico

AU - Bassi, Cristian

AU - Lupini, Laura

AU - Quaglia, Francesca Maria

AU - Urso, Antonio

AU - Bardi, Maria Antonella

AU - Bonaldi, Laura

AU - Volta, Eleonora

AU - Tammiso, Elisa

AU - Ilari, Caterina

AU - Cafforio, Luciana

AU - Melandri, Aurora

AU - Cavazzini, Francesco

AU - Negrini, Massimo

AU - Semenzato, Gianpietro

AU - Trentin, Livio

AU - Foà, Robin

AU - Cuneo, Antonio

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Complex karyotype (CK) is a negative prognostic factor in chronic lymphocytic leukaemia (CLL). However, CK is a heterogeneous cytogenetic category. Unbalanced rearrangements were present in 73·3% of 90 CLL patients with CK (i.e. ≥3 chromosome aberrations in the same clone), and were associated with a shorter overall survival (P = 0·025) and a shorter time to first treatment (P = 0·043) by multivariate analysis. Patients with unbalanced rearrangements presented a distinct mRNA expression profile. In conclusion, CLL patients with unbalanced rearrangements might represent a subset of very high-risk CLL patients with distinct clinical and biological characteristics.

AB - Complex karyotype (CK) is a negative prognostic factor in chronic lymphocytic leukaemia (CLL). However, CK is a heterogeneous cytogenetic category. Unbalanced rearrangements were present in 73·3% of 90 CLL patients with CK (i.e. ≥3 chromosome aberrations in the same clone), and were associated with a shorter overall survival (P = 0·025) and a shorter time to first treatment (P = 0·043) by multivariate analysis. Patients with unbalanced rearrangements presented a distinct mRNA expression profile. In conclusion, CLL patients with unbalanced rearrangements might represent a subset of very high-risk CLL patients with distinct clinical and biological characteristics.

KW - chronic lymphocytic leukaemia

KW - complex karyotype

KW - gene expression profile

KW - overall survival

KW - time to first treatment

UR - http://www.scopus.com/inward/record.url?scp=85045233476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045233476&partnerID=8YFLogxK

U2 - 10.1111/bjh.15174

DO - 10.1111/bjh.15174

M3 - Article

VL - 181

SP - 229

EP - 233

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -